Importance Each year in the US, approximately 100 000 people are treated for cervical
precancer, 14 000 people are diagnosed with cervical cancer, and 4000 die of cervical …

Each year in the United States, nearly 13,000 women develop cervical cancer and 4000 die
from the disease. 1 However, most cases can be prevented with vaccination and screening …

In the next 20 years, cervical cancer screening will have evolved through four phases. The
first was traditional screening, which has been associated with a two-thirds reduction in …

Key Clinical Points Cervical-Cancer Screening with Human Papillomavirus and Cytologic
Cotesting Cervical cancer screening in the United States should not start until the age of 21 …

Cervical cancer screening involves a complex process of cytology, human papillomavirus
(HPV) testing, colposcopy, and a multitude of algorithms for the identification of preinvasive …

Screening in women has decreased the incidence and mortality of cervical cancer.
Precancerous cervical lesions (cervical intraepithelial neoplasias) and cervical carcinomas …

Although cytology-based cervical cancer prevention programs have reduced the incidence
of cervical cancer in many industrialized countries, the limited sensitivity of cervical cytology …

Use of human papillomavirus (HPV) testing in cervical cancer prevention is increasing
rapidly. A DNA test for 13 HPV types that can cause cervical cancer is approved in the …

Cytology-based cervical screening had unequivocal success in reducing the incidence and
mortality of cervical cancer in the last century. The recognition of the role of human …

Background Screening for cervical cancer based on testing for human papillomavirus (HPV)
increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial …